مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

813
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

THE EFFECT OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) ON BONE MINERAL DENSITY (BMD) IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES

Pages

  135-142

Abstract

 Introduction: Decreased rates of bone fracture have been reported in hypercholesterolemic patients treated with statin compounds. Considering the higher prevalence of bone fractures in diabetic patients compared to non-diabetics, this study was performed to determine the effect of LOVASTATIN on the BONE MINERAL DENSITY (BMD) of postmenopausal women with TYPE 2 DIABETES. Materials & Methods: In this clinical trial study, 60 postmenopausal women with TYPE 2 DIABETES were divided into 2 groups (with and without hypercholesterolemia) matched for age, diabetes duration, BMI and duration of menopause. Hypercholesterolemic subjects were treated with LOVASTATIN for 18 months. Using DXA, bone densitometries was performed in all patients before and at the end of the study and the results were compared. Results: Total hip and lumbar spine BMD significantly increased in the treated group (p<0.01). In control subjects BMD decreased in total hip and increased in lumbar spine, but not significantly. Percentage changes of BMD in the femoral neck, wards triangle, trochanter, total hip and lumbar spine were 3.5% ,15.7% , 1.7%,3.29% and 3.2% respectively in the treated group as compared to -2.54% , 3% ,-2.2% , -2.2% and 1.1% in control subjects, respectively. Conclusion: According to our findings, LOVASTATIN can increase the BMD in postmenopausal women with TYPE 2 DIABETES. It seems that these agents may slow the process of OSTEOPOROSIS or stop its progression, especially in hypercholesterolemic patients.      

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    SAFAEI, H., AMINI, MASOUD, & JANGHORBANI, M.. (2005). THE EFFECT OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) ON BONE MINERAL DENSITY (BMD) IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 7(2 (SN 26)), 135-142. SID. https://sid.ir/paper/27866/en

    Vancouver: Copy

    SAFAEI H., AMINI MASOUD, JANGHORBANI M.. THE EFFECT OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) ON BONE MINERAL DENSITY (BMD) IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2005;7(2 (SN 26)):135-142. Available from: https://sid.ir/paper/27866/en

    IEEE: Copy

    H. SAFAEI, MASOUD AMINI, and M. JANGHORBANI, “THE EFFECT OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) ON BONE MINERAL DENSITY (BMD) IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES,” IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 7, no. 2 (SN 26), pp. 135–142, 2005, [Online]. Available: https://sid.ir/paper/27866/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button